Capricor Therapeutics Signs Exclusive Worldwide ...

Capricor Therapeutics Signs Exclusive Worldwide License ...

It has signed an exclusive, worldwide licensing agreement with Johns Hopkins University (JHU) to include engineered exosomes for vaccines and therapeutics.

Capricor Therapeutics Signs Exclusive Worldwide License

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology ...

8-K - Capricor Therapeutics

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome. Platform Technology ...

Capricor Therapeutics Signs Binding Term Sheet with Nippon ...

... worldwide,” said Linda Marbán, Ph.D., Capricor's Chief Executive ... Capricor has entered into an agreement for the exclusive ...

Capricor Therapeutics Signs Exclusive Worldwide License ...

Capricor Therapeutics announced that it has signed an exclusive, worldwide licensing agreement with Johns Hopkins University to include engineered exosomes ...

Capricor Therapeutics Signs Exclusive Worldwide ... - Exosome RNA

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology ...

Capricor Therapeutics Signs Binding Term Sheet with Nippon

... worldwide,” said Linda Marbán, Ph.D., Capricor's Chief Executive Officer ... Capricor has entered into an agreement for the exclusive ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio. Mar 11 ...

Capricor Therapeutics, Inc. Enters Into Exclusive License ... - BioSpace

... therapeutic platform in regenerative medicine. Under the terms of the agreement, Capricor has been granted an exclusive world-wide license ...

Capricor Therapeutics Signs Binding Term Sheet with Nippon ...

... Capricor Therapeutics in their quest to bring deramiocel to DMD patients globally. ... Capricor has entered into an agreement for the exclusive ...

Capricor Therapeutics to Present Long-Term Data from HOPE-2 ...

... of the World Muscle Society (WMS 2024), taking place October 8-12, 2024, in ... Capricor has entered into an agreement for the exclusive ...

Capricor Therapeutics Announces Pricing of Approximately $75 ...

Manufacturing investment signals progression towards late-stage clinical ... Capricor has entered into an agreement for the exclusive ...

capricor | Exosome RNA

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio. April 30 ...

CAPRICOR THERAPEUTICS, INC. Contracts & Agreements | Justia

... Capricor Therapeutics, Inc., Capricor, Inc. and Nippon Shinyaku Co. Ltd (Filed With SEC on March 11, 2022); Exclusive License Agreement, dated as of April 28 ...

10-K Filing - Capricor Therapeutics

The JHU Exosome License Agreement provided for the grant of an exclusive, worldwide, royalty-bearing license of JHU's co-owned rights by JHU to Capricor ...

CAPR Capricor Therapeutics - Reddit

... capricor-therapeutics-signs-exclusive-worldwide-120000417.html. LOS ANGELES, April 29, 2021 (GLOBE NEWSWIRE) --. Capricor Therapeutics. (NASDAQ: CAPR), a ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

Abstract Highlights New Preclinical Data on Exosome-Based Delivery of PMOs for the Treatment of DMD-SAN DIEGO, Nov.

Capricor Therapeutics to Present Third Quarter 2024 Financial ...

International: 1-646-307-1865. Conference ID: 68076. Participants can use guest ... Capricor has entered into an agreement for the exclusive ...

CAPR / Capricor Therapeutics, Inc. - SEC Filings, Annual Report ...

... Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and ... Capricor Therapeutics Enters into Exclusive License with Cedars-Sinai ...

10-K - Capricor Therapeutics

The Amended Mayo Agreement provides for the grant of an exclusive, world-wide, royalty-bearing license by Mayo to the Company (with the right to sublicense) ...